What is the treatment for acute sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Acute Sinusitis

Initial Management: Symptomatic Treatment First

Most cases of acute sinusitis are viral and resolve spontaneously within 7-10 days without antibiotics—start with symptomatic management and reserve antibiotics for specific clinical criteria. 1

Symptomatic Treatment (First-Line for All Patients)

  • Analgesics (acetaminophen or NSAIDs) should be offered for pain relief in all patients with acute sinusitis 1
  • Saline nasal irrigation promotes mucus clearance and temporarily reduces tissue edema 1
  • Intranasal corticosteroids (mometasone, fluticasone, or budesonide twice daily) provide modest but clinically important benefits with a number needed to treat of 14 1, 2
  • Topical nasal decongestants may be used short-term (≤3-5 days) to relieve nasal congestion, but prolonged use leads to rebound congestion 1
  • Systemic decongestants (pseudoephedrine) provide symptomatic relief, though evidence for efficacy is limited 2

When to Start Antibiotics: Three Clinical Patterns

Antibiotics should be reserved for patients meeting one of these three criteria 1, 2:

  1. Persistent symptoms ≥10 days without clinical improvement
  2. Severe symptoms for ≥3 consecutive days (fever ≥39°C/102°F with purulent nasal discharge and facial pain)
  3. "Double sickening": worsening symptoms after initial improvement from a viral upper respiratory infection

Antibiotic Selection

First-Line Antibiotic Therapy

Amoxicillin is the first-line antibiotic choice for uncomplicated acute bacterial sinusitis due to its effectiveness, low cost, and tolerability. 1

  • Standard-dose amoxicillin: 500 mg twice daily for mild disease 3
  • High-dose amoxicillin: 875 mg twice daily for moderate disease or areas with high prevalence of resistant S. pneumoniae 3
  • Treatment duration: 10-14 days or until symptom-free for 7 days 1, 3

For patients at risk of resistant organisms (recent antibiotic use within 4-6 weeks, age <2 years, daycare attendance), use high-dose amoxicillin-clavulanate 875 mg/125 mg twice daily 1, 3

Penicillin-Allergic Patients

For documented penicillin allergy, second- or third-generation cephalosporins are preferred due to negligible cross-reactivity risk. 3

  • Second-generation cephalosporins: Cefuroxime-axetil 3
  • Third-generation cephalosporins: Cefpodoxime-proxetil or cefdinir (superior activity against H. influenzae) 3
  • For severe beta-lactam allergy: Doxycycline 100 mg once daily for 10 days (adults only, not for children <8 years) 3, 2
  • Respiratory fluoroquinolones (levofloxacin 500 mg once daily or moxifloxacin 400 mg once daily for 10 days) should be reserved for severe allergy or treatment failures 3, 4

Critical pitfall: Azithromycin should NOT be used for acute bacterial sinusitis due to resistance rates of 20-25% for S. pneumoniae and H. influenzae 3, 5

Second-Line Therapy for Treatment Failure

If no improvement after 3-5 days of initial antibiotic therapy, switch to a different antibiotic. 1, 3

  • High-dose amoxicillin-clavulanate (4 g amoxicillin/250 mg clavulanate per day) for β-lactamase-producing organisms or drug-resistant S. pneumoniae 3
  • Respiratory fluoroquinolones (levofloxacin 500-750 mg once daily or moxifloxacin 400 mg once daily) provide 90-92% predicted clinical efficacy against resistant pathogens 3, 4
  • Ceftriaxone 1-2 g IM/IV once daily for 5 days for patients unable to tolerate oral medications or with severe disease 3

Adjunctive Therapies

  • Intranasal corticosteroids are beneficial as adjunctive therapy, especially when marked mucosal edema is present 1, 3
  • Short-term oral corticosteroids (typically 5 days) may be considered for patients who fail initial treatment or have marked mucosal edema 1, 3
  • Avoid antihistamines unless the patient has concurrent allergic rhinitis, as they may thicken secretions 1
  • Guaifenesin has theoretical benefits but insufficient evidence in sinusitis 1

Pediatric Dosing

  • Standard-dose amoxicillin: 45 mg/kg/day in 2 divided doses 3
  • High-dose amoxicillin: 80-90 mg/kg/day in 2 divided doses for high-risk children (age <2 years, daycare attendance, recent antibiotic use, or areas with high prevalence of resistant S. pneumoniae) 3
  • High-dose amoxicillin-clavulanate: 80-90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses 3
  • Ceftriaxone: 50 mg/kg IM as a single dose for children unable to tolerate oral medication 3

Treatment Monitoring and Reassessment

  • Reassess at 72 hours (pediatrics) or 3-5 days (adults): If no improvement, switch antibiotics or re-evaluate diagnosis 3
  • Reassess at 7 days: Confirm diagnosis if symptoms persist or worsen 3
  • Complete the full antibiotic course even after symptoms improve to prevent relapse 3

When to Refer to a Specialist

Consider referral to otolaryngology for 1, 2:

  • Sinusitis refractory to two courses of appropriate antibiotics
  • Recurrent sinusitis (≥3 episodes per year)
  • Suspected complications (orbital cellulitis, meningitis, intracranial extension, abscess)
  • Need to clarify allergic or immunologic basis for sinusitis
  • Underlying anatomical abnormalities requiring evaluation

Critical Pitfalls to Avoid

  • Overdiagnosis of bacterial sinusitis: 98-99.5% of acute rhinosinusitis is viral and resolves spontaneously—wait at least 10 days before prescribing antibiotics unless severe symptoms are present 1, 2
  • Using antihistamines in non-allergic patients, which may thicken secretions 1
  • Prolonged use of topical decongestants (>3-5 days), which leads to rebound congestion 1
  • Prescribing azithromycin due to high resistance rates 3
  • Using clindamycin as monotherapy, as it lacks activity against H. influenzae and M. catarrhalis 3
  • Inadequate treatment duration, which can lead to relapse 3
  • Failure to recognize complications requiring urgent intervention 1, 2

References

Guideline

Acute Sinusitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute Rhinosinusitis: Rapid Evidence Review.

American family physician, 2025

Guideline

Treatment of Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.